ABUS vs CHRW · P/E 5.4, rev $6.2M vs P/E 37, rev $17.72B
Arbutus Biopharma Corp (ABUS) versus CH Robinson Worldwide Inc (CHRW) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
CH Robinson Worldwide Inc (CHRW) is a integrated freight & logistics company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CHRW revenue for 2024-12-31 was $17.72B. Net income was $465.7M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
Not investment advice. Open the ABUS and CHRW stock pages for the full models.
Not investment advice.